Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Defining mentoring: a literature review of issues, types, and applications.

Mullen CA, Klimaitis CC.

Ann N Y Acad Sci. 2019 Jul 16. doi: 10.1111/nyas.14176. [Epub ahead of print]

PMID:
31309580
2.

Support of acute lymphoblastic leukemia cells by nonmalignant bone marrow stromal cells.

Usmani S, Sivagnanalingam U, Tkachenko O, Nunez L, Shand JC, Mullen CA.

Oncol Lett. 2019 Jun;17(6):5039-5049. doi: 10.3892/ol.2019.10188. Epub 2019 Mar 22.

3.

Successful reduced-intensity conditioning hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemia in two children.

Andolina JR, Reinish AL, Akhtar R, Noronha S, Shand JC, Girvin A, Korones DN, Bruckner LB, Mullen CA, Curran KJ, Boulad F.

Pediatr Blood Cancer. 2018 Aug;65(8):e27218. doi: 10.1002/pbc.27218. Epub 2018 May 3.

PMID:
29722478
4.

Cover Crop Species and Management Influence Predatory Arthropods and Predation in an Organically Managed, Reduced-Tillage Cropping System.

Rivers AN, Mullen CA, Barbercheck ME.

Environ Entomol. 2018 Apr 5;47(2):340-355. doi: 10.1093/ee/nvx149.

PMID:
29471320
5.

The effect of equiaxial stretching on the osteogenic differentiation and mechanical properties of human adipose stem cells.

Virjula S, Zhao F, Leivo J, Vanhatupa S, Kreutzer J, Vaughan TJ, Honkala AM, Viehrig M, Mullen CA, Kallio P, McNamara LM, Miettinen S.

J Mech Behav Biomed Mater. 2017 Aug;72:38-48. doi: 10.1016/j.jmbbm.2017.04.016. Epub 2017 Apr 13.

PMID:
28448920
6.

Background characterization of an ultra-low background liquid scintillation counter.

Erchinger JL, Orrell JL, Aalseth CE, Bernacki BE, Douglas M, Fuller ES, Keillor ME, Marianno CM, Morley SM, Mullen CA, Panisko ME, Warren GA.

Appl Radiat Isot. 2017 Aug;126:168-170. doi: 10.1016/j.apradiso.2017.01.032. Epub 2017 Jan 26.

PMID:
28236554
7.

Patterns of Diagnosis and Misdiagnosis in Pediatric Cancer and Relationship to Survival.

Chen J, Mullen CA.

J Pediatr Hematol Oncol. 2017 Apr;39(3):e110-e115. doi: 10.1097/MPH.0000000000000688.

PMID:
27782927
8.

Osteocyte differentiation and the formation of an interconnected cellular network in vitro.

Mc Garrigle MJ, Mullen CA, Haugh MG, Voisin MC, McNamara LM.

Eur Cell Mater. 2016 May 24;31:323-40.

9.

Original Research: Acute chest syndrome in sickle cell disease: Effect of genotype and asthma.

Pahl K, Mullen CA.

Exp Biol Med (Maywood). 2016 Apr;241(7):745-58. doi: 10.1177/1535370216636720. Epub 2016 Mar 1.

10.

Development of a low background liquid scintillation counter for a shallow underground laboratory.

Erchinger JL, Aalseth CE, Bernacki BE, Douglas M, Fuller ES, Keillor ME, Morley SM, Mullen CA, Orrell JL, Panisko ME, Warren GA, Williams RO, Wright ME.

Appl Radiat Isot. 2015 Nov;105:209-218. doi: 10.1016/j.apradiso.2015.08.027. Epub 2015 Aug 20.

PMID:
26334781
11.

Optical design considerations for efficient light collection from liquid scintillation counters.

Bernacki BE, Douglas M, Erchinger JL, Fuller ES, Keillor ME, Morley SM, Mullen CA, Orrell JL, Panisko ME, Warren GA, Wright ME.

Appl Opt. 2015 Mar 20;54(9):2413-23. doi: 10.1364/AO.54.002413.

PMID:
25968530
12.

The effect of substrate stiffness, thickness, and cross-linking density on osteogenic cell behavior.

Mullen CA, Vaughan TJ, Billiar KL, McNamara LM.

Biophys J. 2015 Apr 7;108(7):1604-1612. doi: 10.1016/j.bpj.2015.02.022.

13.

Guaiacol hydrodeoxygenation mechanism on Pt(111): insights from density functional theory and linear free energy relations.

Lee K, Gu GH, Mullen CA, Boateng AA, Vlachos DG.

ChemSusChem. 2015 Jan;8(2):315-22. doi: 10.1002/cssc.201402940. Epub 2014 Dec 2.

PMID:
25470789
14.

Bioenergy crops grown for hyperaccumulation of phosphorous in the Delmarva Peninsula and their biofuels potential.

Boateng AA, Serapiglia MJ, Mullen CA, Dien BS, Hashem FM, Dadson RB.

J Environ Manage. 2015 Mar 1;150:39-47. doi: 10.1016/j.jenvman.2014.10.030. Epub 2014 Nov 25.

PMID:
25460422
15.

Bone cell mechanosensation of fluid flow stimulation: a fluid-structure interaction model characterising the role integrin attachments and primary cilia.

Vaughan TJ, Mullen CA, Verbruggen SW, McNamara LM.

Biomech Model Mechanobiol. 2015 Aug;14(4):703-18. doi: 10.1007/s10237-014-0631-3. Epub 2014 Nov 16.

PMID:
25399300
16.

Cell morphology and focal adhesion location alters internal cell stress.

Mullen CA, Vaughan TJ, Voisin MC, Brennan MA, Layrolle P, McNamara LM.

J R Soc Interface. 2014 Dec 6;11(101):20140885. doi: 10.1098/rsif.2014.0885.

17.

Acute lymphoid leukemia cells with greater stem cell antigen-1 (Ly6a/Sca-1) expression exhibit higher levels of metalloproteinase activity and are more aggressive in vivo.

Hsu YC, Mildenstein K, Hunter K, Tkachenko O, Mullen CA.

PLoS One. 2014 Feb 20;9(2):e88966. doi: 10.1371/journal.pone.0088966. eCollection 2014.

18.

Osteocyte differentiation is regulated by extracellular matrix stiffness and intercellular separation.

Mullen CA, Haugh MG, Schaffler MB, Majeska RJ, McNamara LM.

J Mech Behav Biomed Mater. 2013 Dec;28:183-94. doi: 10.1016/j.jmbbm.2013.06.013. Epub 2013 Jul 18.

19.

Aspen Plus® and economic modeling of equine waste utilization for localized hot water heating via fast pyrolysis.

Hammer NL, Boateng AA, Mullen CA, Wheeler MC.

J Environ Manage. 2013 Oct 15;128:594-601. doi: 10.1016/j.jenvman.2013.06.008. Epub 2013 Jul 8.

PMID:
23845952
20.

Reliable peak selection for multisample analysis with comprehensive two-dimensional chromatography.

Reichenbach SE, Tian X, Boateng AA, Mullen CA, Cordero C, Tao Q.

Anal Chem. 2013 May 21;85(10):4974-81. doi: 10.1021/ac303773v. Epub 2013 May 6.

21.

Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea.

Green NS, Ender KL, Pashankar F, Driscoll C, Giardina PJ, Mullen CA, Clark LN, Manwani D, Crotty J, Kisselev S, Neville KA, Hoppe C, Barral S.

PLoS One. 2013;8(2):e55709. doi: 10.1371/journal.pone.0055709. Epub 2013 Feb 7.

22.

"Good enough" medicine: noninferiority clinical trials and the management of fever and neutropenia.

Mullen CA.

Pediatr Blood Cancer. 2012 Sep;59(3):415-6. doi: 10.1002/pbc.24119. Epub 2012 Mar 15. No abstract available.

PMID:
22422727
23.

Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease.

Milner LA, Becker MW, Bernstein SH, Bruckner L, Friedberg JW, Holland GA, Ifthikharuddin JJ, Liesveld JL, Mathes EJ, Menchel HL, Mullen CA, Sasson T, Phillips GL 2nd.

Am J Hematol. 2011 Aug;86(8):712-4. doi: 10.1002/ajh.22075. Epub 2011 May 31. No abstract available.

24.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR; Infectious Diseases Society of America.

Clin Infect Dis. 2011 Feb 15;52(4):e56-93. doi: 10.1093/cid/cir073.

PMID:
21258094
25.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.

Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR; Infectious Diseases Society of Americaa.

Clin Infect Dis. 2011 Feb 15;52(4):427-31. doi: 10.1093/cid/ciq147. Epub 2011 Jan 4.

PMID:
21205990
26.

Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects.

Jansson J, Hsu YC, Kuzin II, Campbell A, Mullen CA.

Leuk Res. 2011 Jun;35(6):800-7. doi: 10.1016/j.leukres.2010.10.018. Epub 2010 Nov 12.

27.

Evidence of B cell immune responses to acute lymphoblastic leukemia in murine allogeneic hematopoietic stem cell transplantation recipients treated with donor lymphocyte infusion and/or vaccination.

Mullen CA, Campbell A, Tkachenko O, Jansson J, Hsu YC.

Biol Blood Marrow Transplant. 2011 Feb;17(2):226-38. doi: 10.1016/j.bbmt.2010.08.021. Epub 2010 Sep 8.

28.

Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant.

Shand JC, Jansson J, Hsu YC, Campbell A, Mullen CA.

Cancer Immunol Immunother. 2010 Nov;59(11):1633-44. doi: 10.1007/s00262-010-0889-y. Epub 2010 Jul 3.

PMID:
20602231
29.

Risk factors for umbilical venous catheter-associated thrombosis in very low birth weight infants.

Narang S, Roy J, Stevens TP, Butler-O'Hara M, Mullen CA, D'Angio CT.

Pediatr Blood Cancer. 2009 Jan;52(1):75-9. doi: 10.1002/pbc.21714.

30.

Asymmetric oxidative cation/olefin cyclization of polyenes: evidence for reversible cascade cyclization.

Mullen CA, Campbell AN, Gagné MR.

Angew Chem Int Ed Engl. 2008;47(32):6011-4. doi: 10.1002/anie.200801423. No abstract available.

31.

High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.

Young FM, Campbell A, Emo KL, Jansson J, Wang PY, Jordan CT, Mullen CA.

Biol Blood Marrow Transplant. 2008 Jun;14(6):622-30. doi: 10.1016/j.bbmt.2008.02.015. Epub 2008 Apr 14.

32.

Regioselective oxidative cation-olefin cyclization of poly-enes: catalyst turnover via hydride abstraction.

Mullen CA, Gagné MR.

J Am Chem Soc. 2007 Oct 3;129(39):11880-1. Epub 2007 Sep 13. No abstract available.

PMID:
17850150
33.

Hematopoietic stem cell recipients do not develop post-transplantation immune tolerance to antigens present on minimal residual disease.

Natzke AM, Shaw JL, McKeller MR, Emo KL, Mullen CA.

Biol Blood Marrow Transplant. 2007 Jan;13(1):34-45.

34.

Interferon-alpha after autologous stem cell transplantation in pediatric patients with advanced Hodgkin's lymphoma.

Petropoulos D, Worth LL, Mullen CA, Lockhart S, Choroszy M, Chan KW.

Bone Marrow Transplant. 2006 Sep;38(5):345-9.

PMID:
16915224
35.
36.

Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.

Quezada G, Sunderland T, Chan KW, Rolston K, Mullen CA.

Pediatr Blood Cancer. 2007 Mar;48(3):273-7.

PMID:
16435377
37.

Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies.

Petropoulos D, Worth LL, Mullen CA, Madden R, Mahajan A, Choroszy M, Ha CS, Champlin RC, Chan KW.

Bone Marrow Transplant. 2006 Mar;37(5):463-7.

PMID:
16435013
38.
39.

Bacterial infections in low-risk, febrile neutropenic patients.

Kamana M, Escalante C, Mullen CA, Frisbee-Hume S, Rolston KV.

Cancer. 2005 Jul 15;104(2):422-6.

41.

Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation.

Tran H, Petropoulos D, Worth L, Mullen CA, Madden T, Andersson B, Choroszy M, Nguyen J, Webb SK, Chan KW.

Biol Blood Marrow Transplant. 2004 Nov;10(11):805-12.

42.

Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.

Mullen CA.

Pediatr Infect Dis J. 2003 Dec;22(12):1138-42. Review.

PMID:
14688588
43.

Fludarabine and once-daily intravenous busulfan for allogeneic bone marrow transplantation for Chediak-Higashi syndrome.

Gordon N, Mullen CA, Tran H, Worth L, Gomez Almaguer D, Chan KW.

J Pediatr Hematol Oncol. 2003 Oct;25(10):824-6.

PMID:
14528111
44.

Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation.

Mori S, El-Baki H, Mullen CA.

Bone Marrow Transplant. 2003 May;31(10):865-75.

PMID:
12748663
45.

Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients.

Mullen CA, Abd El-Baki H, Samir H, Tarrand JJ, Rolston KV.

Support Care Cancer. 2003 May;11(5):321-5. Epub 2003 Mar 11.

PMID:
12720076
47.

Suicide gene therapy using E. coli beta-galactosidase.

Farquhar D, Pan BF, Sakurai M, Ghosh A, Mullen CA, Nelson JA.

Cancer Chemother Pharmacol. 2002 Jul;50(1):65-70. Epub 2002 Jun 8.

PMID:
12111114
48.

Lorazepam for seizure prophylaxis during high-dose busulfan administration.

Chan KW, Mullen CA, Worth LL, Choroszy M, Koontz S, Tran H, Slopis J.

Bone Marrow Transplant. 2002 Jun;29(12):963-5.

50.

Supplemental Content

Loading ...
Support Center